Arteriosclerosis of Arterial Coronary Artery Bypass GraftNCT01559376
Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography
An observational study of Arteriosclerosis of Arterial Coronary Artery Bypass Graft, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 2 sites in Canada.
Trial summary
The objectives of the study are two-fold: 1. To determine the mean 5 year patency rate of the radial artery graft (Open vs. Endoscopic) of patients who have already had CABG surgery and who previously participated in the centre's RCT back in 2005-2007 using CTA and MPS-MIBI 2. Read more about this study
- Who is it for?
- Any ageHealthy volunteers can take part
- Conditions the study is for
- Arteriosclerosis of Arterial Coronary Artery Bypass Graft
- How many people
- 118 participants
- Where
- 2 sitesCanada
- Study dates
- Feb 2012to Feb 2015
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Study population: The patient population consists of patients that have previously participated in our RCT from 2005-2007 with an open or endoscopically harvested radial artery graft used as a bypass conduit. We are following them for 5-year follow up.
Who may be able to join
- Patients will be included if they:
- Have previously participated in our RCT from 2005-2007 with an open or endoscopically harvested radial artery graft used as a bypass conduit.
- Willing to give informed consent to participate in the study
Who cannot join
- Patients are excluded if they are:
- Expired
- Unable or unwilling to give informed consent
- History of allergic reaction to contrast material used in CTA or severe adverse reactions to medications used in MPS-MIBI procedures
- Kidney dysfunction
Trial locations and contacts
2 sites in 1 country.
Canada2 sites
London Health Sciences Centre, University Hospital
London, Ontario, N6A 5A5
London Health Sciences Centre, Victoria Hospital
London, Ontario, N6A 5W9
About this study
The objectives of the study are two-fold:
- To determine the mean 5 year patency rate of the radial artery graft (Open vs. Endoscopic) of patients who have already had CABG surgery and who previously participated in the centre's RCT back in 2005-2007 using CTA and MPS-MIBI
- To determine patient quality of life at 5 years post CABG surgery
It is hypothesized that the mean 5 year patency rate of the radial artery graft harvested endoscopically will be equal to or have greater patency than the radial artery graft harvested via the conventional/open technique. It is further hypothesized that patient quality of life will be similar amongst patients having had the open vs. endoscopic radial artery graft during CABG surgery.
Read the detailed description
After patient consent and REB approval from The University of Western Ontario (REB # 11054) we conducted a Randomized Controlled Trial between 2005-2007 of endoscopic vs. conventional harvesting of the radial artery in CABG patients at the London Health Sciences Centre. A total of 118 patients were randomized to either A) conventional/open harvesting of the radial artery, n=59 or B) endoscopic harvesting of the radial artery, n=59. Post-operative study objectives measured were arm wound infection rate, assessment of arm pain, arm edema, mobilization, patient satisfaction, and histological assessment of the radial artery. Objectives were measured during the patients' course in-hospital and at 1week by telephone interview. At 6 weeks patient underwent a final clinic assessment post-surgery.
Our intent is to perform follow-up angiography and MPS-MIBI at the 5 year mark post surgery on the 118 patients previously involved in our RCT, to assess open vs. endoscopic radial artery graft performance. The study will be divided into three phases: Phase I - Patient Recruitment (4 months), Phase II - Patient Assessment with CTA, MPS-MIBI and Questionnaires (16 months) and Phase III - Data Analysis and Conclusions (4 months).
Phase I - Chart Review and Patient Recruitment (4 Months) Charts will be reviewed on all of the open and endoscopically harvested radial artery grafts used during CABG surgery from the above specified time points. Patient demographics and operative notes, as well as perioperative and postoperative complications will be reviewed. Hospital admissions, documented cardiac events and any subsequent deaths not previously documented will be recorded. Any additional pertinent data from the chart review will be entered into a study specific Microsoft Excel file maintained by a single qualified research assistant.
All living CABG surgery patients will then be contacted and their participation in the study requested. Patients will receive an initial request by mail, with an informative letter signed by the principal investigator outlining the purpose of the study, what participation in the study involves, and the specific aims of the cardiac team at the conclusion of the study. A follow-up phone call will be done within 3-weeks of mailing the letter to go over the content and answer any questions that patients may have.
Phase II - Patient Assessment via CTA, MPS-MIBI and Questionnaires (16 Months)
CABG surgery patients from the previous RCT that agree to be a part of the study will have arrangements made for them to travel to LHSC. Patients will undergo a structured half-day (approximately 4-6 hours) at the hospital consisting of the following:
- Selective coronary artery and radial artery graft check via CTA with a 64 slice CT scanner + Rest MPS-MIBI then Stress MPS-MIBI (4-6hrs). The CT scanner along with the stress/rest MIBI machine are dedicated "Research only" machines. As such, there are no issues with using these research dedicated machines and there is no additional cost to OHIP.
- Completion of two validated health related quality of life questionnaires
- Seattle Angina Questionnaire
- 36-Item Short Form Health Survey SELECTIVE CORONARY ARTERY \& RADIAL ARTERY GRAFT CHECK VIA CTA AND REST \& STRESS MPS-MIBI
Coronary CTA and Rest and Stress MPS-MIBI will be used for evaluating radial artery graft patency. Potential risks associated with CTA and both MPS-MIBI tests will be discussed with each patient prior to performing the procedure. This discussion will include the following:
As CTA is an x-ray test, it sends radiation through the body. Although the amount of radiation for each scan is small, it can accumulate and damage body cells over time with repeated exposure. Contrast material carries a slight risk of causing an allergic reaction to the contrast material or dye. During the Rest and Stress MPS-MIBI, a radioactive tracer (MIBI) is used to take pictures of the heart. This tracer is injected into the bloodstream and travels to the heart muscle through the coronary arteries. Pictures are then taken of the heart to determine coronary artery disease and the perfusion images at rest and stress help identify regions of myocardial infarction as well as help determine the hemodynamic significance of any coronary stenoses. MPS also gives an estimate of the left ventricular ejection fraction. Signed consent will be obtained prior to each procedure. Contrast will be injected into the coronary arteries and the vein grafts and CTA and MPS-MIBI images obtained.
EVALUATING RADIAL ARTERY GRAFT PATENCY All coronary artery and radial artery graft CTAs and MPS-MIBIs will be performed and graded by Nuclear Medicine physicians. Following the patency determination, the patients will be contacted by Dr.Bob Kiaii (cardiac surgeon) and told their results.
Radial artery graft patency will be determined using the grading system of Fitzgibbons and associates:
Grade A Excellent graft with unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
QUALITY OF LIFE QUESTIONNAIRES To assess quality of life 5 years after undergoing CABG surgery and participating in our RCT, each patient will self-administer two validated health-related quality of life questionnaires while on site at LHSC. The two questionnaires to be used are the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey. Licensing and user registration permitting use of these questionnaires will be obtained online from Cardiovascular Outcomes Inc. (SAQ) and Quality Metric (SF-36) prior to their distribution and use.
SEATTLE ANGINA QUESTIONNAIRE The SAQ is a 19-item, well standardized self-administered questionnaire shown to be a valid measure of quality of life in patients suffering from coronary artery disease. The disease-specific questionnaire measures five clinically important dimensions of health in coronary artery disease patients: physical limitations, angina stability, angina frequency, treatment satisfaction and disease perception. The SAQ has shown to be more sensitive to clinical change in coronary artery disease in comparison to more generic quality of life questionnaires.
36-ITEM SHORT FORM HEALTH SURVEY The SF-36 is a 36-item, generic quality of life questionnaire for measuring patient's general health status. Also well-standardized and self-administered, the SF-36 measures eight health concepts: physical conditioning, role limitations due to physical problems, social functioning, bodily pain, and general mental health, role limitations due to emotional problems, vitality and general health perceptions. It also includes an indication of perceived change in health. The questionnaire has proven relevant across age, disease process and treatment group.
Using a disease-specific questionnaire and a general health questionnaire in combination will more aptly categorize the overall impact of the CABG surgery on patient quality of life. The effects of CABG surgery both in regards to cardiovascular function as well as outside systems will be better understood.
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Endoscopic radial artery harvest | Not described | |
| Conventional open radial artery harvest | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Radial artery graft patency
Grade A Excellent graft with unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
Measured: Mean 5 years
Secondary outcomes (4)
Ischemia present in other coronary artery territories
Areas of decreased perfusion identified by MPS-MIBI scanning in the context of CT - angiographic results
Measured: Mean 5 years
Identification of left ventricular ejection fraction at rest and stress
Related in percentage of blood ejected as a fraction of left ventricular end diastolic volume
Measured: Mean 5 years
Quality of life post CABG via the two questionnaires; the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey.
Numerical score based on the questionnaire scoring scales
Measured: Mean 5 years
Stenosis present in other coronary arteries / grafts
Based on CT - angiographic results. Grade A: unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
Measured: Mean 5 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2012 (estimated)
- Study startFeb 2012
- Primary completionFeb 2014
- Study completionFeb 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Arteriosclerosis of Arterial Coronary Artery Bypass GraftStudies of the same condition, open and under way.
- More trials run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Prospective
- Enrolment
- 118 participants (estimated)
Sponsor and investigators
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Bob Kiaii, BSc, MD, Principal investigator, University of Western Ontario, Lawson Research Institute, University of Western Ontario
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01559376
- Sponsor's protocol ID
- ENDO2012
- Status last verified
- Mar 2012
- First submitted
- 27 Feb 2012
- Last updated
- 28 Aug 2017
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Long Term Follow-up of Open Versus Endoscopic Radial Artery Harvest With CT Angiography
- ClinicalTrials.gov ID
- NCT01559376
- Acronym / sponsor ID
- ENDO2012
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 118 participants (estimated)
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sUniversity, hospital or other
- Study start
- Feb 2012
- Primary completion
- Feb 2014 (actual)
- Study completion
- Feb 2015 (actual)
- First posted
- 21 Mar 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The objectives of the study are two-fold:
- To determine the mean 5 year patency rate of the radial artery graft (Open vs. Endoscopic) of patients who have already had CABG surgery and who previously participated in the centre's RCT back in 2005-2007 using CTA and MPS-MIBI
- To determine patient quality of life at 5 years post CABG surgery
It is hypothesized that the mean 5 year patency rate of the radial artery graft harvested endoscopically will be equal to or have greater patency than the radial artery graft harvested via the conventional/open technique. It is further hypothesized that patient quality of life will be similar amongst patients having had the open vs. endoscopic radial artery graft during CABG surgery.
Detailed description
After patient consent and REB approval from The University of Western Ontario (REB # 11054) we conducted a Randomized Controlled Trial between 2005-2007 of endoscopic vs. conventional harvesting of the radial artery in CABG patients at the London Health Sciences Centre. A total of 118 patients were randomized to either A) conventional/open harvesting of the radial artery, n=59 or B) endoscopic harvesting of the radial artery, n=59. Post-operative study objectives measured were arm wound infection rate, assessment of arm pain, arm edema, mobilization, patient satisfaction, and histological assessment of the radial artery. Objectives were measured during the patients' course in-hospital and at 1week by telephone interview. At 6 weeks patient underwent a final clinic assessment post-surgery.
Our intent is to perform follow-up angiography and MPS-MIBI at the 5 year mark post surgery on the 118 patients previously involved in our RCT, to assess open vs. endoscopic radial artery graft performance. The study will be divided into three phases: Phase I - Patient Recruitment (4 months), Phase II - Patient Assessment with CTA, MPS-MIBI and Questionnaires (16 months) and Phase III - Data Analysis and Conclusions (4 months).
Phase I - Chart Review and Patient Recruitment (4 Months) Charts will be reviewed on all of the open and endoscopically harvested radial artery grafts used during CABG surgery from the above specified time points. Patient demographics and operative notes, as well as perioperative and postoperative complications will be reviewed. Hospital admissions, documented cardiac events and any subsequent deaths not previously documented will be recorded. Any additional pertinent data from the chart review will be entered into a study specific Microsoft Excel file maintained by a single qualified research assistant.
All living CABG surgery patients will then be contacted and their participation in the study requested. Patients will receive an initial request by mail, with an informative letter signed by the principal investigator outlining the purpose of the study, what participation in the study involves, and the specific aims of the cardiac team at the conclusion of the study. A follow-up phone call will be done within 3-weeks of mailing the letter to go over the content and answer any questions that patients may have.
Phase II - Patient Assessment via CTA, MPS-MIBI and Questionnaires (16 Months)
CABG surgery patients from the previous RCT that agree to be a part of the study will have arrangements made for them to travel to LHSC. Patients will undergo a structured half-day (approximately 4-6 hours) at the hospital consisting of the following:
- Selective coronary artery and radial artery graft check via CTA with a 64 slice CT scanner + Rest MPS-MIBI then Stress MPS-MIBI (4-6hrs). The CT scanner along with the stress/rest MIBI machine are dedicated "Research only" machines. As such, there are no issues with using these research dedicated machines and there is no additional cost to OHIP.
- Completion of two validated health related quality of life questionnaires
- Seattle Angina Questionnaire
- 36-Item Short Form Health Survey SELECTIVE CORONARY ARTERY \& RADIAL ARTERY GRAFT CHECK VIA CTA AND REST \& STRESS MPS-MIBI
Coronary CTA and Rest and Stress MPS-MIBI will be used for evaluating radial artery graft patency. Potential risks associated with CTA and both MPS-MIBI tests will be discussed with each patient prior to performing the procedure. This discussion will include the following:
As CTA is an x-ray test, it sends radiation through the body. Although the amount of radiation for each scan is small, it can accumulate and damage body cells over time with repeated exposure. Contrast material carries a slight risk of causing an allergic reaction to the contrast material or dye. During the Rest and Stress MPS-MIBI, a radioactive tracer (MIBI) is used to take pictures of the heart. This tracer is injected into the bloodstream and travels to the heart muscle through the coronary arteries. Pictures are then taken of the heart to determine coronary artery disease and the perfusion images at rest and stress help identify regions of myocardial infarction as well as help determine the hemodynamic significance of any coronary stenoses. MPS also gives an estimate of the left ventricular ejection fraction. Signed consent will be obtained prior to each procedure. Contrast will be injected into the coronary arteries and the vein grafts and CTA and MPS-MIBI images obtained.
EVALUATING RADIAL ARTERY GRAFT PATENCY All coronary artery and radial artery graft CTAs and MPS-MIBIs will be performed and graded by Nuclear Medicine physicians. Following the patency determination, the patients will be contacted by Dr.Bob Kiaii (cardiac surgeon) and told their results.
Radial artery graft patency will be determined using the grading system of Fitzgibbons and associates:
Grade A Excellent graft with unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
QUALITY OF LIFE QUESTIONNAIRES To assess quality of life 5 years after undergoing CABG surgery and participating in our RCT, each patient will self-administer two validated health-related quality of life questionnaires while on site at LHSC. The two questionnaires to be used are the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey. Licensing and user registration permitting use of these questionnaires will be obtained online from Cardiovascular Outcomes Inc. (SAQ) and Quality Metric (SF-36) prior to their distribution and use.
SEATTLE ANGINA QUESTIONNAIRE The SAQ is a 19-item, well standardized self-administered questionnaire shown to be a valid measure of quality of life in patients suffering from coronary artery disease. The disease-specific questionnaire measures five clinically important dimensions of health in coronary artery disease patients: physical limitations, angina stability, angina frequency, treatment satisfaction and disease perception. The SAQ has shown to be more sensitive to clinical change in coronary artery disease in comparison to more generic quality of life questionnaires.
36-ITEM SHORT FORM HEALTH SURVEY The SF-36 is a 36-item, generic quality of life questionnaire for measuring patient's general health status. Also well-standardized and self-administered, the SF-36 measures eight health concepts: physical conditioning, role limitations due to physical problems, social functioning, bodily pain, and general mental health, role limitations due to emotional problems, vitality and general health perceptions. It also includes an indication of perceived change in health. The questionnaire has proven relevant across age, disease process and treatment group.
Using a disease-specific questionnaire and a general health questionnaire in combination will more aptly categorize the overall impact of the CABG surgery on patient quality of life. The effects of CABG surgery both in regards to cardiovascular function as well as outside systems will be better understood.
Study design
- Observational model
- Case-control
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Endoscopic radial artery harvest | – | – |
| Conventional open radial artery harvest | – | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
- Study population
- The patient population consists of patients that have previously participated in our RCT from 2005-2007 with an open or endoscopically harvested radial artery graft used as a bypass conduit. We are following them for 5-year follow up.
Key inclusion criteria (3 listed)
- Patients will be included if they:
Key exclusion criteria (5 listed)
- Patients are excluded if they are:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Radial artery graft patency
Time frame: Mean 5 years
Grade A Excellent graft with unimpaired run-off, patent graft Grade B Stenosis reducing caliber of proximal, distal anastomosis or trunk to <50% of the grafted coronary artery. This will be divided into flow limiting and non-flow limiting stenosis Grade O Occlusion
4 secondary outcomes
Ischemia present in other coronary artery territories
Time frame: Mean 5 years
Identification of left ventricular ejection fraction at rest and stress
Time frame: Mean 5 years
Quality of life post CABG via the two questionnaires; the Seattle Angina Questionnaire (SAQ) and the 36-Item Short Form Health Survey.
Time frame: Mean 5 years
Stenosis present in other coronary arteries / grafts
Time frame: Mean 5 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Aug 2017.
Related trials for Arteriosclerosis of Arterial Coronary Artery Bypass Graft
Not yet recruitingPhase 4
Roxadustat and Myocardial Injury After Off-Pump Coronary Artery Bypass Surgery
Coronary Artery Disease, Coronary Artery Bypass Grafting
RecruitingObservational study
Preoperative Gastric Ultrasound and Left Ventricular Function in Coronary Artery Bypass Surgery
Coronary Artery Disease, Left Ventricular Systolic Dysfunction
Not yet recruiting
Partial Cardiac Denervation for Preventing Atrial Fibrillation After CABG
Postoperative Atrial Fibrillation, Coronary Artery Disease
Recruiting
Postural Mobilization Compared to Noradrenaline Only in Off-Pump CABG Surgery
Coronary Artery Disease With Need for Bypass Surgery, Coronary Artery Disease(CAD)
RecruitingPhase 3
A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
Coronary Artery Disease (CAD), Coronary Artery Bypass Graft Surgery(CABG)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bob Kiaii, BSc, MD principal investigator
University of Western Ontario, Lawson Research Institute, University of Western Ontario
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Arteriosclerosis of Arterial Coronary Artery Bypass Graft, run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's at 2 sites in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Radial artery graft patency (time frame: Mean 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2017.